79 related articles for article (PubMed ID: 16438852)
1. [Detection of methylation of hMSH2 gene promoter region of esophageal cancer].
Zhang GY; Ma CX; Liu QL; Le XP; Ding Y; Zhang QX
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):541-3. PubMed ID: 16438852
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hMSH2 gene in esophageal cancer].
Zhang GY; Liu QL; Ma CX; Le XP; Ge XF; Ding Y; Zhang QX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):662-4, 669. PubMed ID: 15201084
[TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
Cong DG; Wang SF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.
Hsu HS; Wen CK; Tang YA; Lin RK; Li WY; Hsu WH; Wang YC
Clin Cancer Res; 2005 Aug; 11(15):5410-6. PubMed ID: 16061855
[TBL] [Abstract][Full Text] [Related]
6. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
8. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
10. MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.
Ling ZQ; Zhao Q; Zhou SL; Mao WM
Eur J Surg Oncol; 2012 Apr; 38(4):326-32. PubMed ID: 22265839
[TBL] [Abstract][Full Text] [Related]
11. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
[TBL] [Abstract][Full Text] [Related]
12. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.
Smith E; Drew PA; Tian ZQ; De Young NJ; Liu JF; Mayne GC; Ruszkiewicz AR; Watson DI; Jamieson GG
Mol Cancer; 2005 Dec; 4():42. PubMed ID: 16351731
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
15. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the CHFR gene in digestive tract cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
18. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
19. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.
Ikoma D; Ichikawa D; Ueda Y; Tani N; Tomita H; Sai S; Kikuchi S; Fujiwara H; Otsuji E; Yamagishi H
Anticancer Res; 2007; 27(1B):535-9. PubMed ID: 17348438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
